Trial Profile
A trial to study efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Diabetic complications
- Focus Therapeutic Use
- Acronyms ESCAPADA
- 20 Dec 2015 New trial record